Cita APA

Ishida, C. T., Zhang, Y., Bianchetti, E., Shu, C., Trang, N. T. T., Kleiner, G., . . . Siegelin, M. D. (2018). Metabolic Reprogramming by Dual AKT/ERK Inhibition Through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. Clin Cancer Res.

Citación estilo Chicago

Ishida, Chiaki T., et al. "Metabolic Reprogramming By Dual AKT/ERK Inhibition Through Imipridones Elicits Unique Vulnerabilities in Glioblastoma." Clin Cancer Res 2018.

Cita MLA

Ishida, Chiaki T., et al. "Metabolic Reprogramming By Dual AKT/ERK Inhibition Through Imipridones Elicits Unique Vulnerabilities in Glioblastoma." Clin Cancer Res 2018.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.